A Study Of Galcanezumab In Participants With Episodic Cluster Headache
Status:
Completed
Trial end date:
2018-06-04
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy and safety of the study drug known
as Galcanezumab in participants with episodic cluster headaches.